Claims for Patent: 10,912,714

✉ Email this page to a colleague

Summary for Patent: 10,912,714

Title:	PECVD coated pharmaceutical packaging
Abstract:	An article or vessel is described including a vessel surface and a coating set comprising at least one tie coating, at least one barrier coating, and at least one pH protective coating. For example, the coating set can comprise a tie coating, a barrier coating, a pH protective coating and a second barrier coating; and in the presence of a fluid composition, the fluid contacting surface is the barrier coating or layer. The respective coatings can be applied by PECVD of a polysiloxane precursor. Such vessels can have a coated interior portion containing a fluid with a pH of 4 to 8. The barrier coating prevents oxygen from penetrating into the thermoplastic vessel, and the tie coating and pH protective coating together protect the barrier layer from the contents of the vessel. The second barrier coating is comparable to glass surface if needed.
Inventor(s):	Weikart Christopher, Clark Becky L., Stevenson Adam, Felts John T.
Assignee:	SiO2 Medical Products, Inc.
Application Number:	US16029923
Patent Claims:

Details for Patent 10,912,714

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emd Serono, Inc.	PERGONAL	menotropins	For Injection	017646	August 22, 1975	⤷ Start Trial	2038-07-09
Emd Serono, Inc.	PERGONAL	menotropins	For Injection	017646	May 20, 1985	⤷ Start Trial	2038-07-09
Eli Lilly And Company	HUMATROPE	somatropin	For Injection	019640	June 23, 1987	⤷ Start Trial	2038-07-09
Eli Lilly And Company	HUMATROPE	somatropin	For Injection	019640	October 16, 1986	⤷ Start Trial	2038-07-09
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,912,714

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201208501	⤷ Start Trial
South Africa	201207881	⤷ Start Trial
South Africa	201107871	⤷ Start Trial
South Africa	201107835	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.